Treatment of Postviral Olfactory Dysfunction

Status Active, not recruiting

Clinical Trial Summary

A decreased sense of smell (hyposmia) is often caused by viral infections, such as COVID-19. Today, the only recommended treatment for hyposmia is olfactory training, a time consuming method with limitations in terms of both compliance and effect. The aim of this study is therefore to evaluate, as well as optimize, a new treatment method for olfactory loss. Hyposmic participants will be recruited and randomized into two different treatment conditions. One group will do regular olfactory training and the other will do passive olfactory training with scented nose plugs. The training will be conducted in the home of the individual monday through friday for two consecutive months. Subjective and objectvie measures of olfactory problems will be assessed before and after treatment, as well as subjective measures related to quality of live and genereal wellbeing.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06142565
Study type	Interventional
Source	Karolinska Institutet
Contact
Status	Active, not recruiting
Phase	N/A
Start date	October 17, 2023
Completion date	June 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06019000` - Study of CYR-064 Versus Placebo in Patients.	Phase 2
Completed	`NCT05445921` - Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction	Phase 1/Phase 2
Completed	`NCT04853836` - Olfactory Disfunction and Co-ultraPEALut	Phase 4
Completed	`NCT05152030` - The Clinical Applicability of the 'TIB' Olfactory Test Device
Recruiting	`NCT05837637` - The Vietnamese Smell Identification Test in the Diagnosis of Parkinson's Disease
Recruiting	`NCT05384561` - Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19	N/A
Not yet recruiting	`NCT04661800` - Study of Olfactory Disorders in Patients With Cardiac Amyloidosis	N/A
Completed	`NCT04789499` - Smell in Covid-19 and Efficacy of Nasal Theophylline	Phase 2
Recruiting	`NCT05364125` - Olfactory Training on Smell Dysfunction Patients in HK	N/A
Completed	`NCT05461365` - Intranasal Insulin for COVID-19-related Smell Loss	Phase 3
Completed	`NCT04710394` - Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell	N/A
Completed	`NCT05184192` - Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction	Phase 2
Not yet recruiting	`NCT05421221` - Olfactory Training in COVID-19 Associated Loss of Smell	N/A